MedTrace Logo

Effectiveness of Hyaluronic Acid in the Regeneration of Infrabony Defects

NCT04319770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-06-04

No results posted yet for this study

Summary

The purpose of this randomized controlled clinical trial (RCT) is to determine the efficacy hyaluronic acid (HA) versus enamel matrix derivatives (EMD) in the treatment of infrabony periodontal defects.

Conditions

  • Intrabony Periodontal Defect

Interventions

DEVICE

enamel matrix derivative (EMD)

periodontal regenerative surgery with enamel matrix derivative (EMD) (control)

DEVICE

hyaluronic acid (HA)

periodontal regenerative surgery with hyaluronic acid (HA) (test)

Sponsors & Collaborators

  • University of Roma La Sapienza

    lead OTHER

Principal Investigators

  • Andrea Pilloni, MD,DDS,MS · University of Roma La Sapienza

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-06
Primary Completion
2019-10-21
Completion
2019-10-21

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04319770 on ClinicalTrials.gov